SBI Cross-Border Advantage Fund Overview
SBI Cross-Border Advantage Fund General Information
Description
SBI Cross-Border Advantage Fund is a venture capital fund managed by SBI Investment Korea Company. The fund is located in Seoul, South Korea and invests in South Korea. The fund targets chemicals and gases, commercial products, cleantech and TMT sectors.
Contact Information
Fund Manager's Location
- 14th floor, NC Tower I, 509 Teheran-ro
- Gangnam-gu
- Seoul, 06169
- South Korea
SBI Cross-Border Advantage Fund Investments (20)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| LactoMason | 04-May-2021 | Other Pharmaceuticals and Biotechnology | Generating Revenue | |||
| Xcell | 18-Mar-2021 | Drug Discovery | Generating Revenue | |||
| Immunobiome | 01-Sep-2020 | Biotechnology | Pre-Clinical Trials | |||
| Uppthera | 14-Jul-2020 | Drug Discovery | Generating Revenue | |||
| Odd Concepts | 30-Mar-2020 | Business/Productivity Software | Generating Revenue | |||
| OncoInsight | 04-Feb-2020 | Biotechnology | Generating Revenue | |||
| Buzzvil | 21-Jan-2020 | Business/Productivity Software | Generating Revenue | |||
| Supertree | 21-Jan-2020 | Entertainment Software | Generating Revenue | |||
| Fast Five | 18-Jun-2019 | Later Stage VC (Series D) | Buildings and Property | Generating Revenue | ||
| Fresheasy | 15-Feb-2019 | Early Stage VC | Food Products | Generating Revenue |
SBI Cross-Border Advantage Fund Investment Strategy
Investments by Industry
Investments by Deal Type
SBI Cross-Border Advantage Fund Returns Data
The below charts are illustrative of the type of graphical data available to our clients and do not represent live data.
IRR (%)
DPI (x)
RVPI (x)
TVPI (x)
SBI Cross-Border Advantage Fund Benchmark (74)
| Fund Name | Fund Type | Vintage | IRR | Quartile | As of Date |
|---|---|---|---|---|---|
| Asus Fund | |||||
| North Pacific SDGs Promotion Fund | |||||
| Life.SRED MDEC Fintech Fund | |||||
| Nomura FinTech Fund | |||||
| The Digital Innovation Fund | |||||
| Drum Tower Ventures TM Fund I | |||||
| Gazelle Fund | |||||
| Artesian China Venture Fund | |||||
| 021 Capital Fund | |||||
| HighLight Capital II US Dollar-Denominated Fund | 31-Dec-2022 |
SBI Cross-Border Advantage Fund FAQs
-
What is SBI Cross-Border Advantage Fund?
SBI Cross-Border Advantage Fund is a venture capital fund managed by SBI Investment Korea Company.
-
Who manages SBI Cross-Border Advantage Fund?
SBI Cross-Border Advantage Fund is managed by SBI Investment Korea Company.
-
Where is SBI Cross-Border Advantage Fund domiciled?
SBI Cross-Border Advantage Fund is domiciled in South Korea.
-
What is SBI Cross-Border Advantage Fund's size?
SBI Cross-Border Advantage Fund has a size of .
-
What type of fund is SBI Cross-Border Advantage Fund?
The fund type of SBI Cross-Border Advantage Fund is Venture.
-
What is the status of SBI Cross-Border Advantage Fund?
SBI Cross-Border Advantage Fund is closed.
-
What has SBI Cross-Border Advantage Fund invested in?
SBI Cross-Border Advantage Fund has made numerous investments in companies like LactoMason, Xcell, and Immunobiome within the Pharmaceuticals and Biotechnology, Drug Discovery, and Biotechnology industries.
-
What has SBI Cross-Border Advantage Fund invested in recently?
SBI Cross-Border Advantage Fund's latest investment was on 04-May-2021 in LactoMason, a company within the Pharmaceuticals and Biotechnology industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
